Nutrition
Volume 19, Issue 3 , Pages 213-228 , March 2003

Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: Effect of ω-3 fatty acids

  • Y Suresh, PhD

      Affiliations

    • EFA Sciences LLC, Norwood, Massachusetts, USA
    • ,
  • U.N Das, MD, FAMS

      Affiliations

    • EFA Sciences LLC, Norwood, Massachusetts, USA
    • Corresponding Author InformationCorrespondence to: U. N. Das, MD, FAMS, EFA Sciences LLC, 1420 Providence Highway, Suite 266, Norwood, MA 02062, USA.

References 

  1. Nielsen JH. Affinity purified human interleukin-1 is cytotoxic to isolated islets of Langerhans. Diabetologia. 1986;29:63
  2. Dunger A, Cunningham JM, Delaney CA, et al.  Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned rat islets (extent of nitric oxide involvement). Diabetes. 1996;45:183
  3. Das UN. Inhibition of sensitized lymphocyte response to sperm antigen(s) by prostaglandins. IRCS Med Sci. 1981;9:1087
  4. Su CG, Wen X, Bailey ST, et al.  A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J Clin Invest. 1999;104:383
  5. Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, et al.  Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun. 1998;244:678
  6. Higa M, Zhou YT, Ravazzola M, et al.  Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci USA. 1999;96:11513
  7. Fukuzawa M, Satoh J, Qiang X, et al.  Inhibition of tumor necrosis factor-alpha with anti-diabetic agents. Diabetes Res Clin Pract. 1999;43:147
  8. Chew BP, Wong TS, Shultz TD, Magnuson NS. Effects of conjugated dienoic derivatives of linoleic acid and beta-carotene in modulating lymphocyte and macrophage function. Anticancer Res. 1997;17(2A):1099
  9. Hayek MG, Han SN, Wu D, et al.  Dietary conjugated linoleic acid influences the immune response of young and old C57BL/6NCr1BR mice. J Nutr. 1999;129:32
  10. Suresh Y, Das UN. Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids. 2001;64:37
  11. Mohan IK, Das UN. Prevention of chemically induced diabetes mellitus in experimental animals by polyunsaturated fatty acids. Nutrition. 2001;17:126
  12. Mossman T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55
  13. Hodgson VJ, Walker GM, Button A. A rapid colorimetric assay of killer activity in yeast. FEMS Microbiol Lett. 1994;120:201
  14. Cunnane SC, Keeling PW, Thompson RP, Crawford MA. Linoleic acid and arachidonic acid metabolism in human peripheral blood leucocytes (comparison with the rat). Br J Nutr. 1984;51:209
  15. Das UN, Huang YS, Begin ME, Ells G, Horrobin DF. Uptake and distribution of cis-unsaturated fatty acids and their effect on free radical generation in normal and tumor cells in vitro. Free Radic Biol Med. 1987;3:9
  16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning (a laboratory manual). In: 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1989;p. 9.14
  17. Mohan IK, Das UN. Effect of L-arginine-nitric oxide system on chemical-induced diabetes mellitus. Free Radic Biol Med. 1998;25:757
  18. Green LC, Wagner DA, Glogowski J, et al.  Analysis of nitrate, nitrite and N15 nitrite in biological fluids. Anal Biochem. 1982;26:131
  19. Bernheim S, Bernheim MLC, Wilbar KM. The reaction between thiobarbituric acid and the oxidation products of certain lipids. J Biol Chem. 1948;174:257
  20. Das UN. Tumoricidal action of cis-unsaturated fatty acids and its relationship to free radicals and lipid peroxidation. Cancer Lett. 1991;56:235
  21. Ravin HA. An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med. 1961;58:161
  22. Drabkin DL, Austin JH. Spectrophotometric studies (preparation from washed blood cells, nitric oxide, haemoglobin and sulfahaemoglobin). J Biol Chem. 1988;112:51
  23. McCord JM, Fridovich I. Superoxide dismutase. An enzyme function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244:6049
  24. Aebi H. Catalase. In: Methods in enzymology. Vol 105:New York: Academic Press; 1984;p. 121
  25. Tomita T, Lacy PE, Natschinsky FM, McDaniel ML. Effect of alloxan on insulin secretion in isolated rat islets perfused in vitro. Diabetes. 1974;23:517
  26. Borg LA, Eide SJ, Anderson A, Hellerstrom C. Effects in vitro of alloxan on the glucose metabolism of mouse pancreatic β cells. Biochem J. 1979;182:797
  27. Ishibashi F, Sato T, Onari K, Kawata R. Alloxan inhibits glucose oxidation in the pancreatic islets. Endocrinol Jpn. 1979;26:395
  28. Heikkila RE, Winston B, Cohen G. Alloxan induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate. Biochem Pharmacol. 1976;25:1085
  29. Grankvist K, Marklund S, Sehlin J, Taljedal IB. Superoxide dismutase, catalase and scavengers of hydroxyl radicals protect against toxic action of alloxan on pancreatic islet cells in vitro. Biochem J. 1979;182:17
  30. Boquist L. Factors affecting the beta cell sensitivity to alloxan in vivo. Influence of pre- and post-treatment with protective substances. Acta Endocrinol (Copenh). 1978;88:556
  31. Laight DW, Kaw AV, Carrier MJ, Anggard EE. Interaction between superoxide anion and nitric oxide in the regulation of vascular endothelial function. Br J Pharmacol. 1998;124:238
  32. Das UN. Nutritional factors in the pathobiology of human essential hypertension. Nutrition. 2001;17:337
  33. Fischer PJ, Hamburger SA. Inhibition of alloxan action in isolated pancreatic islets by superoxide dismutase, catalase and a metal chelator. Diabetes. 1980;29:213
  34. Gandy SE, Buse NG, Crouch RK. Protective role of superoxide dismutase against diabetogenetic drugs. J Clin Invest. 1982;70:650
  35. Sandhya LS, Ramesh RB. Protective mechanism of glucose against streptozotocin-induced free radical generation in pancreatic islets in vivo and in vitro. Curr Sci. 1999;76:231
  36. Hiramatsu K, Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes. 1980;29:251
  37. Mohan IK, Das UN. Oxidant stress, anti-oxidants and nitric oxide in non-insulin dependent diabetes mellitus. Med Sci Res. 1997;25:55
  38. Hattori Y, Kawasaki H, Abe K, Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol. 1991;261:H1086
  39. Das UN, Kumar KV, Mohan IK. Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy. J Nutr Med. 1994;4:149
  40. Corbett JA, McDaniel ML. Does nitric oxide mediate autoimmune destruction of beta cells? Possible therapeutic interventions in IDDM. Diabetes. 1992;41:897
  41. Kroncke KD, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun. 1991;175:752
  42. Kolb H, Kolb-Bachofen V. Nitric oxide (a pathogenetic factor in autoimmunity). Immunol Today. 1992;13:157
  43. Fehsel K, Jalowy A, Qi S, et al.  Islet cell DNA damage is a target of inflammatory attack by nitric oxide. Diabetes. 1993;42:496
  44. Jurgen R, Birgit H, Alexander B, et al.  Nitric oxide toxicity in islet cells involves poly (ADP-ribose) polymerase activation and concomitant NAD depletion. Biochem Biophys Res Commun. 1994;199:1270
  45. Yamada K, Nonaka K, Hanafusa T, et al.  Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation on nonobese diabetic (NOD) mice. Diabetes. 1982;31:749
  46. Burkart V, Wang Z-Q, Radons J, et al.  Mice lacking the poly(ADP-ribose) polymerase gene are resistant to beta-cell destruction and diabetes development induced by streptozotocin. Nat Med. 1999;5:314
  47. Das UN. Essential fatty acids, lipid peroxidation and apoptosis. Prostaglandins Leukot Essent Fatty Acids. 1999;61:157
  48. Roza AM, Pieper GM, Johnson CP, Adams MB. Pancreatic antioxidant enzyme activity in normoglycemic diabetic prone BB rats. Pancreas. 1995;10:53
  49. Godin DV, Wohaieb SA, Garnett ME, Goumeniouk AD. Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem. 1988;84:223
  50. Garg MC, Ojha S, Bansal DD. Antioxidant status of streptozotocin diabetic rats. Ind J Exp Biol. 1996;34:264
  51. Suresh Y, Das UN. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of ω-6 fatty acids. Nutrition 2002(in press)
  52. Pottathil JD, Huang SW, Chandrabose KA. Essential fatty acids in diabetes and systemic lupus erythematosus patients. Biochem Biophys Res Commun. 1985;128:803
  53. Dang AQ, Kemp K, Faas FH, Carter WJ. Effect of dietary fats on fatty acid composition and delta-5-desaturase in normal and diabetic rats. Lipids. 1989;24:882
  54. Mercuri O, Peluffo RO, Brenner RR. Depression of microsomal desaturation of linoleic to gamma-linolenic acid in the alloxan diabetic rat. Biochim Biophys Acta. 1966;116:409
  55. Tilvis RS, Miettinen TA. Fatty acid compositions of serum lipids, erythrocytes and platelets in insulin-dependent diabetic women. J Clin Endocrinol Metab. 1985;61:741
  56. Das UN. Insulin resistance and hyperinsulinemia (are they secondary to an alteration in the metabolism of essential fatty acids?). Med Sci Res. 1994;22:243
  57. McVeigh GE, Brennan GM, Johnston GD, et al.  Dietary fish oil augments nitric oxide production or release in patients with type 2 diabetes mellitus. Diabetologia. 1993;36:33
  58. Venkatraman JT, Chandrasekhar B, Kim JD, Fernandes G. Effect of n-3 and n-6 fatty acids on the activities of expression of hepatic antioxidant enzymes in auto-immune-prone NZB x NZW mice. Lipids. 1994;29:561
  59. Mohan IK, Das UN. Oxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids. 1997;56:193
  60. Zawalich WS, Diaz VA. Interleukin-1 inhibits insulin secretion from isolated perfused rat islets. Diabetes. 1986;35:1119
  61. Campbell IL, Iscaro A, Harrison LC. IFN-gamma and tumor necrosis factor-alpha (cytotoxicity of murine islets of Langerhans). J Immunol. 1988;141:2325
  62. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, Lakey JR, Rajotte RV. Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J Clin Endocrinol Metab. 1996;81:3197
  63. Endres S, Ghorbani R, Kelley VE, et al.  The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989;320:265
  64. Kumar SK, Das UN. Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot Essent Fatty Acids. 1994;50:331
  65. Santoli D, Zurier RB. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E–independent mechanism. J Immunol. 1989;143:1303
  66. Kumar SK, Das UN, Kumar KV, et al.  Effect of n-6 and n-3 fatty acids on the proliferation and secretion of TNF and IL-2 by human lymphocytes in vitro. Nutr Res. 1992;12:815
  67. Horrobin DF, Carmichael TA. Essential fatty acids in relation to diabetes. In:  Horrobin DF editors. Treatment of diabetic neuropathy. A new approach. Edinburgh: Churchill-Livingstone; 1992;p. 21
  68. Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of type 1 diabetes in the offspring. Diabetologia. 2000;43:1093
  69. Salmeron J, Hu FB, Manson JE, et al.  Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr. 2001;73:1019
  70. Das UN. Essential fatty acids in health and disease. J Assoc Phys India. 1999;47:906
  71. Das UN. Essential fatty acids (biology and their clinical implications). Asia Pac J Pharmacol. 1991;6:317
  72. Schrezenmeir J, Jagla A. Milk and diabetes. J Am Coll Nutr. 2000;19:176S

PII: S0899-9007(02)00855-9

doi: 10.1016/S0899-9007(02)00855-9

Nutrition
Volume 19, Issue 3 , Pages 213-228 , March 2003

Article Tools

* Image Usage & Resolution